Roble Belko & Company’s Organon & Co OGN Stock Holding History

Roble Belko & Company’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	22	–	–	﹤0.01%	477
2026 Q1	$0	Hold	22	–	–	﹤0.01%	492
2025 Q4	$0	Hold	22	–	–	﹤0.01%	503
2025 Q3	$0	Hold	22	–	–	﹤0.01%	472
2025 Q2	$0	Hold	22	–	–	﹤0.01%	460
2025 Q1	$0	Buy	+22	New	+$338	﹤0.01%	433
2024 Q2	–	Sell	-19	Closed	–	–	361
2024 Q1	$0	Hold	19	–	–	﹤0.01%	346
2023 Q4	$0	Hold	19	–	–	﹤0.01%	340
2023 Q3	$0	Hold	19	–	–	﹤0.01%	313
2023 Q2	$0	Hold	19	–	–	﹤0.01%	318
2023 Q1	$0	Hold	19	–	–	﹤0.01%	318
2022 Q4	$1K	Hold	19	–	–	﹤0.01%	305
2022 Q3	$0	Hold	19	–	–	﹤0.01%	335
2022 Q2	$1K	Hold	19	–	–	﹤0.01%	304
2022 Q1	$1K	Hold	19	–	–	﹤0.01%	360
2021 Q4	$1K	Hold	19	–	–	﹤0.01%	331
2021 Q3	$1K	Sell	19 -477	-96%	-$15.3K	﹤0.01%	307
2021 Q2	$15K	Buy	+496	New	+$16.3K	﹤0.01%	242

Other funds holding OGN

PMG

Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

TMAM

Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return

CIEC

Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Roble Belko & Company's OGN Position: Q2 2026 in Review

Roble Belko & Company held its Organon & Co (OGN) position steady in Q2 2026 at 22 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Roble Belko & Company first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $15K in Q2 2021. 295 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Roble Belko & Company held 22 shares of Organon & Co worth $0 as of Q2 2026.
Roble Belko & Company left its Organon & Co share count unchanged in Q2 2026.
Organon & Co made up ﹤0.01% of Roble Belko & Company's portfolio in Q2 2026, its #477 holding.
Roble Belko & Company first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
Roble Belko & Company's Organon & Co position peaked at $15K in Q2 2021.
295 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Roble Belko & Company's 13F filing for Q2 2026, filed 24 Jul 2026.